Suppr超能文献

妇科恶性肿瘤盆腔廓清术后手术并发症的预测因素:一项大型单机构经验。

Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience.

机构信息

Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, UOC Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

UOC di Nutrizione Clinica, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

出版信息

J Gynecol Oncol. 2024 Jan;35(1):e4. doi: 10.3802/jgo.2024.35.e4. Epub 2023 Sep 11.

Abstract

OBJECTIVE

To evaluate pre-operative predictors of early (<30 days) severe complications (grade Dindo 3+) in patients with gynecological malignancy submitted to pelvic exenteration (PE).

METHODS

We retrospectively analyzed 129 patients submitted to surgery at Fondazione Policlinico Gemelli between 2010 and 2019. We included patients affected by primary or recurrent/persistent cervical, endometrial, or vulvar/vaginal cancers. Post-operative complications were graded according to the Dindo classification. Logistic regression was used to analyze potential predictors of complications.

RESULTS

We performed 63 anterior PE, 10 posterior PE, and 56 total PE. The incidence of early severe post-operative complications was 27.9% (n=36), and the early mortality rate was 2.3% (n=3). More frequent complications were related to the urinary diversion and intestinal surgery. In univariable analysis, hemoglobin ≤10 g/dL (odds ratio [OR]=4.2; 95% confidence interval [CI]=1.65-10.7; p=0.003), low albumin levels (OR=3.9; 95% CI=1.27-12.11; p=0.025), diabetes (OR=4.15; 95% CI=1.22-14.1; p=0.022), 2+ comorbidities at presentation (OR=5.18; 95% CI=1.49-17.93; p=0.012) were predictors of early severe complications. In multivariable analysis, only low hemoglobin and comorbidities at presentation were independent predictors of complications.

CONCLUSION

Pelvic exenteration is an aggressive surgery characterized by a high rate of post-operative complications. Pre-operative assessment of comorbidities and patient health status are crucial to better select the right candidate for this type of surgery.

摘要

目的

评估妇科恶性肿瘤患者行盆腔廓清术(PE)后早期(<30 天)严重并发症(Dindo 分级 3+)的术前预测因素。

方法

我们回顾性分析了 2010 年至 2019 年在 Fondazione Policlinico Gemelli 接受手术的 129 名患者。我们纳入了原发性或复发性/持续性宫颈癌、子宫内膜癌或外阴/阴道癌患者。根据 Dindo 分级系统对术后并发症进行分级。使用逻辑回归分析并发症的潜在预测因素。

结果

我们进行了 63 例前盆腔廓清术、10 例后盆腔廓清术和 56 例全盆腔廓清术。早期严重术后并发症的发生率为 27.9%(n=36),早期死亡率为 2.3%(n=3)。更常见的并发症与尿流改道和肠道手术有关。单变量分析显示,血红蛋白≤10g/dL(比值比[OR]=4.2;95%置信区间[CI]1.65-10.7;p=0.003)、低白蛋白水平(OR=3.9;95%CI1.27-12.11;p=0.025)、糖尿病(OR=4.15;95%CI1.22-14.1;p=0.022)、就诊时存在 2+合并症(OR=5.18;95%CI1.49-17.93;p=0.012)是早期严重并发症的预测因素。多变量分析显示,只有低血红蛋白和就诊时的合并症是并发症的独立预测因素。

结论

盆腔廓清术是一种具有高术后并发症发生率的侵袭性手术。术前评估合并症和患者健康状况对于更好地选择此类手术的合适患者至关重要。

相似文献

2
Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Gynecol Oncol. 2019 Jan;152(1):151-156. doi: 10.1016/j.ygyno.2018.10.036. Epub 2018 Nov 8.
3
Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
World J Gastroenterol. 2006 Feb 21;12(7):1115-9. doi: 10.3748/wjg.v12.i7.1115.
6
Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Int J Gynecol Cancer. 2013 May;23(4):755-62. doi: 10.1097/IGC.0b013e318287a874.
7
Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration.
Int J Gynecol Cancer. 2018 Jun;28(5):975-982. doi: 10.1097/IGC.0000000000001251.
8
Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Surg Oncol. 2022 Mar;40:101702. doi: 10.1016/j.suronc.2021.101702. Epub 2022 Jan 5.
9
Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
Actas Urol Esp (Engl Ed). 2018 Mar;42(2):121-125. doi: 10.1016/j.acuro.2017.05.004. Epub 2017 Sep 12.
10
Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Gynecol Oncol. 2009 Jul;114(1):64-8. doi: 10.1016/j.ygyno.2009.03.029. Epub 2009 May 2.

引用本文的文献

2
Intraoperative Radiation Therapy (IORT) in Gynecologic Cancers: A Scoping Review.
Cancers (Basel). 2025 Apr 18;17(8):1356. doi: 10.3390/cancers17081356.
3
Efficacy and safety of camrelizumab for the treatment of cervical cancer: a systematic review and meta-analysis.
Front Oncol. 2024 Dec 24;14:1526103. doi: 10.3389/fonc.2024.1526103. eCollection 2024.
6
Modified posterior pelvic exenteration combined with ileocecal resection for locally advanced endometrial cancer.
J Gynecol Oncol. 2025 Mar;36(2):e31. doi: 10.3802/jgo.2025.36.e31. Epub 2024 Sep 2.
7
Imaging in pelvic exenteration-a multidisciplinary practice guide from the ESGAR-SAR-ESUR-PelvEx collaborative group.
Eur Radiol. 2025 May;35(5):2681-2691. doi: 10.1007/s00330-024-10940-z. Epub 2024 Aug 25.
9
ASO Author Reflections: Quality of Life After Extended Pelvic Surgery.
Ann Surg Oncol. 2024 Apr;31(4):2753-2754. doi: 10.1245/s10434-023-14705-8. Epub 2023 Dec 6.

本文引用的文献

8
Evolution of pelvic exenteration surgery- resectional trends and survival outcomes over three decades.
Eur J Surg Oncol. 2019 Dec;45(12):2325-2333. doi: 10.1016/j.ejso.2019.07.015. Epub 2019 Jul 8.
10
Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
J Minim Invasive Gynecol. 2019 Nov-Dec;26(7):1316-1326. doi: 10.1016/j.jmig.2018.12.019. Epub 2019 Jan 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验